nach oben

Erschienen in:

05.05.2018 | Original Article

The correlation between striatal and cortical binding ratio of ¹¹C-PiB-PET in amyloid-uptake-positive patients

verfasst von: Julia Sauerbeck, Kazunari Ishii, Chisa Hosokawa, Hayato Kaida, Franziska T. Scheiwein, Kohei Hanaoka, Axel Rominger, Matthias Brendel, Peter Bartenstein, Takamichi Murakami

Erschienen in: Annals of Nuclear Medicine | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In subjects with amyloid deposition, striatal accumulation of ¹¹C-Pittsburgh compound B (PiB) demonstrated by positron emission tomography (PET) is related to the stage of Alzheimer’s disease (AD). In this study, we investigated the correlation between striatal and cortical non-displaceable binding potential (BP_ND).

Methods

Seventy-three subjects who complained of cognitive disturbance underwent dynamic PiB-PET studies and showed positive PiB accumulation were retrospectively selected. These subjects included 34 AD, 26 mild cognitive impairment, 2 frontotemporal lobar degeneration, 2 Parkinson’s disease, 5 dementia with Lewy bodies, and 4 undefined diagnosis patients. Individual BP_ND images were produced from the dynamic data of the PiB-PET study, and voxel-based analyses were performed to estimate the correlations between striatal and other regional cortical BP_ND measures.

Results

There were highly significant correlations between striatal and prefrontal BP_ND, with the highest correlation being demonstrated in left Brodmann area 11. We found that almost all of the high cortical BP_ND values correlated with striatal BP_ND values, with the exception of the occipital cortex with low correlation.

Conclusion

Our study demonstrated positive correlations in amyloid deposits between the striatum and other cortical areas with functional and anatomical links. The amyloid distribution in the brain is not random, but spreads following the functional and anatomical connections.

Wortmann M. Dementia: a global health priority—highlights from an ADI and World Health Organization report. Alzheimers Res Ther. 2012;4:40. https://doi.org/10.1186/alzrt143.PubMedPubMedCentralCrossRef

Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann Neurol. 1999;45:358 – 68.CrossRefPubMed

Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–59.CrossRefPubMed

Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The consortium to establish a registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology. 1991;41:479–86.CrossRefPubMed

Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, Klunk WE. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem. 2003;46:2740–54. https://doi.org/10.1021/jm030026b.CrossRefPubMed

Hatsuta H, Takao M, Ishii K, Ishiwata K, Saito Y, Kanemaru K, et al. Amyloid beta accumulation assessed with (1)(1)C-Pittsburgh compound B PET and postmortem neuropathology. Curr Alzheimer Res. 2015;12:278–86.CrossRefPubMed

Leinonen V, Alafuzoff I, Aalto S, Suotunen T, Savolainen S, Nagren K, et al. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol. 2008;65:1304–9. https://doi.org/10.1001/archneur.65.10.noc80013.CrossRefPubMed

Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease. Brain. 2008;131:1630–45. https://doi.org/10.1093/brain/awn016.CrossRefPubMedPubMedCentral

Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, et al. Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25:7709–17. https://doi.org/10.1523/JNEUROSCI.2177-05.2005.CrossRefPubMed

10.

Ishibashi K, Ishiwata K, Toyohara J, Murayama S, Ishii K. Regional analysis of striatal and cortical amyloid deposition in patients with Alzheimer’s disease. Eur J Neurosci. 2014;40:2701–6. https://doi.org/10.1111/ejn.12633.CrossRefPubMed

11.

Scheiwein TF, Ishii K, Hosokawa C, Kaida H, Hyodo T, Hanaoka K, et al. Regional differences in amyloid deposition between 11C-PiB PET positive patients with and without elevated striatal amyloid uptake. J Alzheimer Dis Parkinsonism. 2017;7:317. https://doi.org/10.4172/2161-0460.1000317.CrossRef

12.

Hosokawa C, Ishii K, Kimura Y, Hyodo T, Hosono M, Sakaguchi K, et al. Performance of 11C-pittsburgh compound B PET binding potential images in the detection of amyloid deposits on equivocal static images. J Nucl Med. 2015;56:1910–5. https://doi.org/10.2967/jnumed.115.156414.CrossRefPubMed

13.

Calcagni ML, Lavalle M, Mangiola A, Indovina L, Leccisotti L, De Bonis P, et al. Early evaluation of cerebral metabolic rate of glucose (CMRglu) with 18F-FDG PET/CT and clinical assessment in idiopathic normal pressure hydrocephalus (INPH) patients before and after ventricular shunt placement: preliminary experience. Eur J Nucl Med Mol Imaging. 2012;39:236 – 41. https://doi.org/10.1007/s00259-011-1950-6.CrossRefPubMed

14.

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer’s disease. Neurology. 1984;34:939–44.CrossRefPubMed

15.

McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863–72. https://doi.org/10.1212/01.wnl.0000187889.17253.b1.CrossRefPubMed

16.

Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.CrossRefPubMed

17.

Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985–92.CrossRefPubMed

18.

Hosokawa C, Ishii K, Hyodo T, Sakaguchi K, Usami K, Shimamoto K, et al. Investigation of (11)C-PiB equivocal PET findings. Ann Nucl Med. 2015;29:164–9. https://doi.org/10.1007/s12149-014-0924-8.CrossRefPubMed

19.

Ishii K, Hosokawa C, Hyodo T, Sakaguchi K, Usami K, Shimamoto K, et al. Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition. Ann Nucl Med. 2015;29:78–83. https://doi.org/10.1007/s12149-014-0911-0.CrossRefPubMed

20.

Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834–40. https://doi.org/10.1097/00004647-199609000-00008.CrossRefPubMed

21.

Kemppainen NM, Aalto S, Wilson IA, Nagren K, Helin S, Bruck A, et al. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology. 2006;67:1575–80. https://doi.org/10.1212/01.wnl.0000240117.55680.0a.CrossRefPubMed

22.

Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306–19. https://doi.org/10.1002/ana.20009.CrossRefPubMed

23.

Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58:1791–800.CrossRefPubMed

24.

Yaqub M, Tolboom N, Boellaard R, van Berckel BN, van Tilburg EW, Luurtsema G, et al. Simplified parametric methods for [11C]PIB studies. NeuroImage. 2008;42:76–86. https://doi.org/10.1016/j.neuroimage.2008.04.251.CrossRefPubMed

25.

Kimura Y, Naganawa M, Shidahara M, Ikoma Y, Watabe H. PET kinetic analysis—pitfalls and a solution for the Logan plot. Ann Nucl Med. 2007;21:1–8.CrossRefPubMed

26.

Gottfried JA, Dolan RJ. Human orbitofrontal cortex mediates extinction learning while accessing conditioned representations of value. Nat Neurosci. 2004;7:1144–52. https://doi.org/10.1038/nn1314.CrossRefPubMed

27.

Cooch NK, Stalnaker TA, Wied HM, Bali-Chaudhary S, McDannald MA, Liu TL, et al. Orbitofrontal lesions eliminate signalling of biological significance in cue-responsive ventral striatal neurons. Nat Commun. 2015;6:7195. https://doi.org/10.1038/ncomms8195.CrossRefPubMedPubMedCentral

28.

Rolls ET, Hornak J, Wade D, McGrath J. Emotion-related learning in patients with social and emotional changes associated with frontal lobe damage. J Neurol Neurosurg Psychiatry. 1994;57:1518–24.CrossRefPubMedPubMedCentral

29.

Burton AC, Bissonette GB, Lichtenberg NT, Kashtelyan V, Roesch MR. Ventral striatum lesions enhance stimulus and response encoding in dorsal striatum. Biol Psychiatry. 2014;75:132–9. https://doi.org/10.1016/j.biopsych.2013.05.023.CrossRefPubMed

30.

Wallis JD. Orbitofrontal cortex and its contribution to decision-making. Annu Rev Neurosci. 2007;30:31–56. https://doi.org/10.1146/annurev.neuro.30.051606.094334.CrossRefPubMed

31.

Yamamoto DJ, Woo CW, Wager TD, Regner MF, Tanabe J. Influence of dorsolateral prefrontal cortex and ventral striatum on risk avoidance in addiction: a mediation analysis. Drug Alcohol Depend. 2015;149:10–7. https://doi.org/10.1016/j.drugalcdep.2014.12.026.CrossRefPubMedPubMedCentral

32.

de Siqueira AS, Yokomizo JE, Jacob-Filho W, Yassuda MS, Aprahamian I. Review of decision-making in game tasks in elderly participants with Alzheimer Disease and mild cognitive impairment. Dement Geriatr Cogn Disord. 2017;43:81–8. https://doi.org/10.1159/000455120.CrossRefPubMed

33.

Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol. 2001;11:240–9.CrossRefPubMed

34.

Vogt BA, Vogt L, Farber NB, Bush G. Architecture and neurocytology of monkey cingulate gyrus. J Comp Neurol. 2005;485:218–39. https://doi.org/10.1002/cne.20512.CrossRefPubMedPubMedCentral

35.

Davey CG, Harrison BJ, Yucel M, Allen NB. Regionally specific alterations in functional connectivity of the anterior cingulate cortex in major depressive disorder. Psychol Med. 2012;42:2071–81.CrossRefPubMed

36.

Trupe LA, Varma DD, Gomez Y, Race D, Leigh R, Hillis AE, et al. Chronic apraxia of speech and Broca’s area. Stroke. 2013;44:740–4. https://doi.org/10.1161/STROKEAHA.112.678508.CrossRefPubMedPubMedCentral

37.

Lauro LJ, Tettamanti M, Cappa SF, Papagno C. Idiom comprehension: a prefrontal task? Cereb Cortex. 2008;18:162–70. https://doi.org/10.1093/cercor/bhm042.CrossRefPubMed

38.

Lepage M, Ghaffar O, Nyberg L, Tulving E. Prefrontal cortex and episodic memory retrieval mode. Proc Natl Acad Sci USA. 2000;97:506–11.CrossRefPubMed

39.

Leech R, Sharp DJ. The role of the posterior cingulate cortex in cognition and disease. Brain. 2014;137:12–32. https://doi.org/10.1093/brain/awt162.CrossRefPubMed

40.

Nakano K, Kayahara T, Tsutsumi T, Ushiro H. Neural circuits and functional organization of the striatum. J Neurol. 2000;247(Suppl 5):V1-15.PubMed

41.

Yang YK, Yao WJ, McEvoy JP, Chu CL, Lee IH, Chen PS, et al. Striatal dopamine D2/D3 receptor availability in male smokers. Psychiatry Res. 2006;146:87–90. https://doi.org/10.1016/j.pscychresns.2005.09.008.CrossRefPubMed

Titel: The correlation between striatal and cortical binding ratio of 11C-PiB-PET in amyloid-uptake-positive patients
verfasst von: Julia Sauerbeck
Kazunari Ishii
Chisa Hosokawa
Hayato Kaida
Franziska T. Scheiwein
Kohei Hanaoka
Axel Rominger
Matthias Brendel
Peter Bartenstein
Takamichi Murakami
Publikationsdatum: 05.05.2018
Verlag: Springer Japan
Erschienen in: Annals of Nuclear Medicine / Ausgabe 6/2018
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI: https://doi.org/10.1007/s12149-018-1258-8

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate

Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer

Publisher Correction to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival

Comparison of 125I- and 111In-labeled peptide probes for in vivo detection of oxidized low-density lipoprotein in atherosclerotic plaques

Implications of electrocardiographic frontal QRS axis on left ventricular diastolic parameters derived from electrocardiogram-gated myocardial perfusion single photon emission computed tomography

718F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival